Pages
Health Care News
Categories
- Asthma education
- Autism
- Canadian Health&Care Mall
- Cardiac function
- Critical Care Units
- Follicle
- Health
- health care medical transport
- health care programs
- Health&Care Professionals
- Hemoptysis
- Hormone
- Isoforms
- Nitroglycerin Patches
- Profile of interleukin-10
- Progesterone
- Pulmonary Function
- Sertoli Cells
- Theophylline
- Tracheoesophageal Fistula
Canadian Health&Care; MallVisit the most reliable Canadian Health&Care; Mall offering a wide choice of drugs for any medical emergency you may have, from male health to infections and obesity! Making sure you always spend less money is among our top priorities! |
Bronchoscopy in North America: The ACCP Survey (16)
Laser Bronchoscopy
Only 11.3 percent (98) of the 871 respondents were involved in laser bronchoscopy. Of these, 38.8 percent (38) used the FFB exclusively, 18.4 percent (18) used only the rigid bronchoscope, 42.8 percent (42) used each at some point in their practice, and one did not provide an answer. The Nd:YAG laser was used by 83.7 percent (82) of the 98 respondents; the argon dye laser, by 4.1 percent (4); the C02 laser, by 3.1 percent (3); and other types of lasers, by the rest.
Comments: There are several possible reasons why only a small number of pulmonary specialists are involved in laser bronchoscopy: laser procedures require special technical skills and specially trained personnel; the equipment required is expensive and not cost-effective unless a large number of laser procedures are performed; and adequate facilities for training in laser bronchoscopy are lacking. As a result, many patients are referred to larger centers which specialize in this procedure. More than one third of the bronchoscopists reported using the FFB exclusively.
Indications
When the respondents were asked to list the five most common indications for bronchoscopy in their practice, several entities were mentioned (Table 7).
Table 7— The Five Most Common Indications for Bronchoscopy
Indications | Respondents, % (n) |
Mass/nodule/suspicious lesion/cancer | 96.4 (840) |
Hemoptysis/bleeding | 81.1 (706) |
Pneumonia/infection | 65.1 (567) |
Diffuse/interstitial disease in | 62.1 (541) |
nonimmunocompromised patient | |
Therapeutic bronchoscopy for lobar | 56.4 (491) |
or segmental atelectasis | |
Cough/wheeze | 23.4 (204) |
Immunocompromised patient | 15.4 (134) |
AIDS/HIV positive | 14.7 (128) |
Trachea/stridor | 2.2 (19) |
ICU/ventilator | 1.5 (13) |
Other! | 4.7 (41) |
Tags: bronchoscopist bronchoscopy fluoroscopy nonimmunocompromised patients